Party consensus    Cooperative endeavours    Forging a stronger partnership    Live score: Chelsea v FC Porto (UEFA Champions League)    Ramadan and the pandemic in Egypt    Human rights vs coronavirus in Egypt    'MySafeUni Day' highlights fight against sexual harassment in universities    Egypt's trade deficit widens by 6.6% during H1 of FY20/2021, CBE    Opportune time for archaeotourism    Parliament discusses new budget    Ora Developers signs an agreement with Telecom Egypt for communication services at its projects    Sisi directs to speed up implementation of digitisation initiative in Egypt    34 projects worth $3.3bn aim to achieve gender equality in Egypt: Al-Mashat    Sisi greets Egyptians, Muslim, Arab nations on occasion of Ramadan    Art Alert: Bahgaga to bring fun to Cairo's Zamalek Theatre with comedy music monologues    Tatweer Misr signs EGP 3.2bn worth investment contracts for Bloomfields educational zone    The endangered River Nile    Water wars    Egypt highlights anti-climate change efforts during Spring Meetings    Don't miss AUC's Lions of Cairo ensemble concert    Prominent American rapper and actor DMX dies at 50    Al-Sisi, Lavrov address bilateral cooperation, Ethiopia's disputed dam    Tehran vows revenge    Narrative Summit launches 1st episode of Reshaping Norms 2021    Russia offers technical assistance in Nile dam negotiation: Lavrov    2021 Copenhagen Documentary Festival to launch Big Digital Live Platform    Egyptian artists honoured at Cairo Opera House for taking part in Golden Parade    Abu Dhabi's ADNOC, Sawiris-backed OCI reportedly weigh IPO of fertiliser joint venture    Russian FM says Egypt is main partner in Middle East, Africa    Bayern Munich, Liverpool needing comebacks to reach CL semifinals    Borussia Dortmund's Sancho back in training before City clash    Cleopatra Hospitals, Nahda University sign EGP 7.4m MoU for joint scholarship programme    Egyptian-African Relations Committee discusses strengthening Egypt's stance in Africa    Egypt will not allow internal water crisis due to Ethiopian dam: Water Minister    Egypt's Public Prosecution announces results of investigations into Sohag train crash    Egypt sees an uptick in new coronavirus infections registers 801 new cases on Saturday    Ethiopia invites Egypt, Sudan to nominate operators in data exchange on GERD's 2nd filling    PMI moves towards a smoke-free transformation, takes part in a webinar on e-cigarettes    Zamalek's Shikabala nominated for best goal in CAF Champions League    Egypt's national youth fencing team achieves world glory    Karate Federation celebrates success of Egypt Cup    Egypt's President warns of grave consequences of water crises in Africa    Allianz Egypt partners with IGNITE to equip brand ambassadors for 2021 Olympics    Hassan Allam consortium wins contract to manage, operate Grand Egyptian Museum    Enhanced Labs signs Mr. Olympia 2020 "Big Ramy" And His Trainer Dennis James    King Tutankhamun funerary mask is must-see tourist icon: The Telegraph    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    Egypt, Ethiopia, Sudan to resume Nile dam talks today    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Germany approves first human trials of new coronavirus vaccine
Published in Amwal Al Ghad on 23 - 04 - 2020

Germany's Federal Institute for Vaccines has approved on Wednesday the first human trials of a potential coronavirus vaccine developed by German biotech company BioNTech.
The trial will see 200 healthy participants between the age of 18 and 55 receive several variants of BioNTech's vaccine as scientists examine its efficacy in providing immunity against the virus.
In a second stage, additional tests will be conducted on more people, including those at higher risk from the coronavirus.
Named BNT162, BioNTech said it was developing this vaccine candidate in cooperation with pharmaceutical giant Pfizer.
BNT162 is also expected to be trialled in the U.S., once regulatory approval for testing on humans had been secured there.
To date, the pandemic has killed more than 177,000 people and infected 2.5 million, according to figures from Johns Hopkins University.
There are 86 teams across the globe currently working to develop a coronavirus vaccine, including a handful at the clinical trial stage.
Germany is second country in Europe, after the UK, approving a human trial.
On Tuesday, British health secretary Matt Hancock announced scientists at Oxford University will start testing a vaccine on people this Thursday.
Around 500 volunteers are expected to take part in the programme by mid-May, with the British government pledging £20 million ($1.26 million) to the Oxford research.
Earlier this month, China approved early-stage human tests for two experimental vaccines, according to state media Xinhua.
These Chinese vaccines are being developed by a Beijing-based unit of Nasdaq-listed Sinovac Biotech and by the Wuhan Institute of Biological Products, a subsidiary of state-run China National Pharmaceutical Group.
In March, authorities in China approved another clinical trial for a vaccine candidate developed by the Academy of Military Medical Sciences and HK-listed biotech company CanSino Bio.
In the United States, drug developer Moderna has started human tests for their vaccine with the U.S. National Institutes of Health.


Clic here to read the story from its source.